Top of page

Experience

To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.

Filters

Pop Mart HK$5.2 billion IPO and Hong Kong listing
Davis Polk advised Pop Mart International Group Limited in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in reliance…
Bluescape Opportunities Acquisition $575 million IPO
Davis Polk advised the joint book runners in connection with the initial public offering of 57,500,000 units of Bluescape Opportunities Acquisition Corp. for aggregate proceeds of $575…
Soltec Power Holdings €150 million IPO
Davis Polk advised Soltec Power Holdings, S.A. on the Rule 144A/Regulation S initial public offering by Soltec Power Holdings of 31,146,717 of its ordinary shares. The initial public…
Track & Field R$454.8 million IPO
Davis Polk advised Track & Field Co S.A. and the selling shareholders in connection with Track & Field’s initial public offering of 49,166,000 preferred shares for an aggregate…
Yellowstone Acquisition $125 million IPO
Davis Polk advised the sole book runner in connection with the initial public offering of 12,500,000 units of Yellowstone Acquisition Company for aggregate proceeds of $125 million…
Rocket Companies $1.8 billion IPO and NYSE listing
Davis Polk advised the representatives of the several underwriters in connection with the initial public offering by Rocket Companies, Inc. of 100,000,000 shares of Rocket Companies’ Class…
Tigermed HK$10.7 billion IPO and Hong Kong listing
Davis Polk advised Hangzhou Tigermed Consulting Co., Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international offering in…
Royalty Pharma $2.5 billion IPO
Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $2.5 billion initial public offering of 89,333,920 of its Class A ordinary shares, which included an…
Back to top